Evommune, Inc. (EVMN) Operating cash flow 2024–2025
Evommune, Inc. (EVMN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$76.4MFY2025 · since FY2024: -$58.2M → -$76.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.4M | -31.4% |
| FY2024 | -$58.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EVMN financial trends
EVMN RevenueEVMN Net incomeEVMN Net marginEVMN Gross profitEVMN Gross marginEVMN Operating incomeEVMN Operating marginEVMN Free cash flowEVMN Capital expendituresEVMN Return on equityEVMN Stock buybacksEVMN Dividends paidEVMN Total assetsEVMN Total liabilitiesEVMN Shareholders’ equityEVMN overview →